The estimated Net Worth of Michael Rosenblatt is at least $1.58 Million dollars as of 1 May 2015. Michael Rosenblatt owns over 3,818 units of Brooks Automation stock worth over $1,539,136 and over the last 10 years he sold BRKS stock worth over $0. In addition, he makes $36,740 as Director at Brooks Automation.
Michael Rosenblatt BRKS stock SEC Form 4 insider trading
Michael has made over 4 trades of the Brooks Automation stock since 2013, according to the Form 4 filled with the SEC. Most recently he exercised 3,818 units of BRKS stock worth $170,168 on 1 May 2015.
The largest trade he’s ever made was exercising 15,000 units of Brooks Automation stock on 19 February 2013 worth over $668,550. On average, Michael trades about 1,522 units every 44 days since 2010. As of 1 May 2015 he still owns at least 34,533 units of Brooks Automation stock.
You can see the complete history of Michael Rosenblatt stock trades at the bottom of the page.
Michael Rosenblatt biography
Dr. Michael Rosenblatt, M.D. is Director of the Company. Dr. Rosenblatt currently serves as Chief Medical Officer of Flagship Pioneering, a Cambridge, Massachusetts-based firm that originates new biotech companies. Prior to Flagship Pioneering, from 2009 through 2016, he was Executive Vice President and Chief Medical Officer of Merck & Co., Inc., and prior to that he held various academic positions, including as Dean of Tufts University School of Medicine and the Robert Ebert Professor of Molecular Medicine and George R. Minot Professor at Harvard Medical School. Since 2015 Dr. Rosenblatt has been on the board of Rubius Therapeutics, a publicly traded company using advanced cellular approaches that harness properties of red blood cells to generate novel therapies. He has been a director of the following privately owned companies since 2016: Flagship Pioneering’s Cobalt Biomedicine, Cygnal Therapeutics, and Ohana Biosciences, and Ferring’s USA subsidiary. Dr. Rosenblatt is a member of the Harvard Medical School Board of Fellows, and the research advisory committees of Massachusetts General, Brigham and Women’s, and Boston Children’s hospitals.
What is the salary of Michael Rosenblatt?
As the Director of Brooks Automation, the total compensation of Michael Rosenblatt at Brooks Automation is $36,740. There are 14 executives at Brooks Automation getting paid more, with Stephen Schwartz having the highest compensation of $3,926,000.
How old is Michael Rosenblatt?
Michael Rosenblatt is 71, he’s been the Director of Brooks Automation since 2018. There are 4 older and 11 younger executives at Brooks Automation. The oldest executive at Brooks Automation, Inc. is A. Clinton Allen, 75, who is the Independent Director.
What’s Michael Rosenblatt’s mailing address?
Michael’s mailing address filed with the SEC is ONE MERCK DRIVE, , WHITEHOUSE STATION, NJ, 08889-0100.
Insider trading at Brooks Automation
Over the last 16 years, insiders at Brooks Automation have traded over $41,752,927 worth of Brooks Automation stock and bought 84,885 units worth $755,883 . The most active insider traders include A Clinton Allen, Amin J Khoury, and Stephen S Schwartz. On average, Brooks Automation executives and independent directors trade stock every 25 days with the average trade being worth of $484,164. The most recent stock trade was executed by Jason Joseph on 24 October 2019, trading 5,478 units of BRKS stock currently worth $232,815.
What does Brooks Automation do?
Brooks Automation, Inc. engages in the provision of automation and cryogenic solutions for multiple markets, including semiconductor capital equipment and life science biological sample management and storage. It operates through the following business segments: Brooks Semiconductor Solutions Group; and Brooks Life Science Systems. The Brooks Semiconductor Solutions Group segment include atmospheric and vacuum robots, robotic modules and tool automation systems that provide precision handling and clean wafer environments, as well as cryogenic pumps and compressors that provide vacuum pumping and thermal management solutions used to create and control critical process vacuum applications. The Brooks Life Science Systems segment provides automated cold sample management systems for compound and biological sample storage, equipment for sample preparation and handling, consumables, and parts and support services to a range of life science customers including pharmaceutical companies, biotechnology companies, bio-banks and research institutes. The company was founded in 1978 and is headquartered in Chelmsford, MA.
What does Brooks Automation’s logo look like?
Complete history of Michael Rosenblatt stock trades at Brooks Automation, Merck & Co, and Rubius Therapeutics
Brooks Automation executives and stock owners
Brooks Automation executives and other stock owners filed with the SEC include:
- Stephen Schwartz, President, Chief Executive Officer, Director
- Lindon Robertson, Chief Financial Officer, Executive Vice President
- David Jarzynka, Senior Vice President, General Manager of Brooks Semiconductor Solutions Group
- David Gray, Senior Vice President, Chief Strategy and New Business Officer
- William Montone, Senior Vice President – Human Resources
- Joseph Martin, Independent Chairman of the Board
- Ellen Zane, Independent Director
- John McGillicuddy, Independent Director
- Krishna Palepu, Independent Director
- Alfred Woollacott, Independent Director
- A. Clinton Allen, Independent Director
- Mark Wrighton, Independent Director
- Kirk Pond, Independent Director
- Robyn Davis, Independent Director
- Michael Rosenblatt, Director
- Sherry Dinsmore, IR Contact Officer
- David Pietrantoni, Principal Accounting Officer, Vice President – Finance, Corporate Controller
- Jason Joseph, Senior Vice President, General Counsel, Secretary
- Maurice H. Tenney, President-Brooks Life Sciences
- Sally White, SVP, Global Services
- Chong Sup Park, Director
- A. Michaud Steven, SVP, Critical Components Group
- John Lillig, SVP, MD, Brooks Life Sciences
- Guojuan Liao, President, GENEWIZ
- Marvin G Schorr,
- Gregory Marvell, VP, Extended Factory Group
- Robert Lepofsky, Director
- Shaun Wilson, VP, Global Customer Operations
- Thomas S Grilk, Sr. VP and General Counsel
- Ralf K Wuellner, President, Global Cust Op Grp
- Juergen Giessmann, Director
- Amin J Khoury, Director
- Charles M Mckenna, Executive VP
- Steven P Wentzell, SVP, Human Resources
- Jeffrey A Cassis, SVP, Global Sales and Service
- Santo Dinaro, SVP, Hardware Automation Group
- Peter Frasso, SVP Global Operations
- Roger D Emerick, Director
- Joseph Bellini, S.V.P. Software Group
- Robert J Therrien, PRESIDENT
- Investment Management Cod3 …,
- Michael W Pippins, Sr VP Corporate Marketing
- Robert W Jr Woodbury, SVP and CFO
- Richard Small, VP Corporate Controller
- James Gentilcore, President & COO
- Robert E Anastasi, Executive Vice President
- Edward C Grady, President and COO
- Mark D Morelli, EVP – Chief Operating Officer
- Martin S Headley, EVP & Chief Financial Officer
- Thomas Leitzke, SVP, Global Operations
- Kush Mirchandani, SVP, Worldwide Sales
- Timothy S Mathews, Principal Accounting Officer
- Clinton M. Haris, VP, Systems Solutions Group
